Pathology - G2 Intelligence

AI Model Detects Genetic Colorectal Cancer Markers from Routine Tissue Slides

Model links tumor morphology with multiple genetic alterations, offering faster diagnostics

Start a Free Trial for immediate access to this article

Already a member? Log in here

Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025

Start a Free Trial for immediate access to this article

Already a member? Log in here

Experts Nathan Buchbinder and Julianna Ianni discuss digital pathology and AI trends in 2024—and what the next year may hold

Start a Free Trial for immediate access to this article

Already a member? Log in here

The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow

Start a Free Trial for immediate access to this article

Already a member? Log in here

The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon

Start a Free Trial for immediate access to this article

Already a member? Log in here